Эволюция диагностики инфаркта миокарда: от Q/не‑Q к STEMI/NSTEMI и парадигме OMI/NOMI

От Q/не‑Q инфаркта к STEMI/NSTEMI: что изменилось и почему

Зачем вообще понадобилась смена концепции

Классификации инфаркта миокарда (ИМ) менялись не из академического интереса, а потому что менялась цель диагностики.

В эпоху Q/не‑Q ключевой вопрос звучал так: какой это ИМ по глубине/объёму некроза и каков прогноз?* В эпоху STEMI/NSTEMI главный вопрос стал другим: нужна ли немедленная реперфузия (тромболизис/первичное ЧКВ) прямо сейчас?*

Этот сдвиг произошёл на фоне появления эффективной реперфузионной терапии и более чувствительных биомаркеров некроза (тропонинов).

!Схема показывает, как менялась цель классификаций: от описания уже случившегося повреждения к раннему распознаванию коронарной окклюзии

Что означала парадигма Q/не‑Q

Определения простыми словами

Патологический зубец Q на ЭКГ — признак того, что участок миокарда уже утратил электрическую активность из‑за некроза, и вектор деполяризации сместился. Патологическим обычно считают Q, который:

Становится достаточно широким/глубоким (в конкретных критериях есть нюансы по отведениям).

Появляется после развития некроза, то есть часто не в самые ранние часы.

Отсюда классификация:

* Q‑инфаркт — ИМ, после которого сформировались патологические Q. * не‑Q инфаркт — ИМ без патологических Q (часто меньший по объёму или с иным распределением повреждения).

Почему эта классификация была логичной в своё время

В докомпьютерную и дореперфузионную эпоху Q/не‑Q:

давала грубую оценку объёма и трансмуральности* поражения; * частично коррелировала с риском осложнений; * опиралась на доступный инструмент — ЭКГ.

Почему Q/не‑Q перестала удовлетворять клиническим задачам

Ключевые ограничения Q/не‑Q (важно: это не «ошибка», а ограничение метода):

Запоздалость признака

Q‑волна часто появляется спустя часы и даже сутки. А реперфузионное лечение эффективно, когда счёт идёт на минуты.

Слабая связь с механизмом события

Наличие/отсутствие Q плохо отвечает на вопрос: есть ли сейчас острая окклюзия коронарной артерии, требующая немедленного восстановления кровотока?

Зависимость от лечения

Реперфузия (особенно ранняя) может уменьшать объём некроза и менять вероятность формирования Q. То есть Q становится не столько маркером исходной катастрофы, сколько отражением того, насколько быстро восстановили кровоток.

Ретроспективность

По сути, Q/не‑Q — классификация, удобная после того, как событие уже случилось, а не для раннего триажа.

Что подтолкнуло переход к STEMI/NSTEMI

Реперфузионная терапия и потребность в быстрых критериях

С появлением тромболизиса и затем первичного ЧКВ возникла необходимость:

* быстро выделять пациентов, которым реперфузия даст наибольшую пользу; * минимизировать задержку принятия решения.

ЭКГ‑признак, который оказался наиболее практичным для этого, — подъём сегмента ST в типичных условиях.

Какие исследования повлияли на закрепление подхода (логика доказательств)

Исторически тромболитические исследования показали, что:

Фибринолитики снижают смертность у пациентов с клиникой острого ИМ.

Наибольшая и наиболее воспроизводимая польза наблюдалась у групп с подъёмом ST (и в ряде работ — при «эквивалентах», таких как новая блокада левой ножки пучка Гиса, хотя позже подход уточнялся).

Классические вехи (как примеры исследований, формировавших практику):

* GISSI-1 (Lancet, 1986) — одно из крупных исследований тромболизиса, повлиявших на принятие реперфузии как стандартного подхода. * ISIS-2 (Lancet, 1988) — показало пользу стрептокиназы и аспирина, усилив идею раннего лечения. * FTT Collaborative Group (Lancet, 1994) — мета‑обзор показаний к фибринолизу в «подозрении на ИМ», где ЭКГ‑паттерны (в частности ST‑подъём) играли ключевую роль для выбора пациентов.

Важный практический вывод той эпохи: для запуска немедленной реперфузии нужен быстрый, воспроизводимый и максимально «у постели пациента» критерий. Таким критерием стал STEMI.

Что означает парадигма STEMI/NSTEMI

Определения

* STEMI (ИМпST) — инфаркт миокарда, при котором на ЭКГ есть подъём сегмента ST в диагностических критериях (в соответствующих отведениях и при учёте клиники). * NSTEMI (ИМбпST) — инфаркт миокарда без диагностического подъёма ST; диагноз обычно подтверждается клиникой и повышением маркеров некроза (в современной практике прежде всего тропонинами).

Параллельно изменилось и лабораторное «ядро» диагноза ИМ: тропонины позволили выявлять более мелкие некрозы, которые раньше могли классифицироваться как нестабильная стенокардия.

* ESC/ACC консенсус о переопределении ИМ (2000) — один из ключевых документов, закрепивших роль тропонинов. * Четвёртое универсальное определение ИМ (2018) — современная рамка диагностики ИМ на основе биомаркеров и клинического контекста.

Что реально изменилось в клинической логике

STEMI/NSTEMI — это, по сути, триажная классификация:

* STEMI — «скорее всего нужен немедленный реперфузионный маршрут». * NSTEMI — «реперфузия может быть нужна, но решение часто менее срочное и базируется на риске/динамике и дополнительных данных».

Именно срочность и организация потоков пациентов (катетеризационная лаборатория, тромболизис на догоспитальном этапе) сделали STEMI/NSTEMI чрезвычайно жизнеспособной моделью.

Почему STEMI/NSTEMI не является точной моделью для диагностики острой коронарной окклюзии

Критически важно разделить два понятия:

* ИМ — факт некроза миокарда (обычно по тропонину + клиника/ЭКГ/визуализация). Острая коронарная окклюзия — механизм, при котором артерия закрыта (или почти закрыта) и миокард прямо сейчас* ишемизируется так, что время до реперфузии определяет объём необратимого повреждения.

STEMI/NSTEMI использует подъём ST как суррогат окклюзии. Но суррогат не равен механизму.

Почему возможна окклюзия без STEMI

Есть ситуации, когда окклюзия или критическая ишемия не проявляются «классическим» подъёмом ST:

Задний (постериорный) ИМ

На стандартной ЭКГ он часто выглядит как депрессия ST в V1–V3 (зеркальное отражение), и без дополнительных задних отведений подъёма ST «не видно».

Окклюзия проксимальной ПНА с паттерном de Winter

Это вариант ЭКГ при острой окклюзии передней нисходящей артерии, где вместо подъёма ST наблюдаются характерные изменения (например, восходящая депрессия ST в прекардиальных отведениях с высокими симметричными T). * de Winter et al., описание паттерна (2008)

ЭКГ «маскируется» исходными изменениями

Например, при блокадах, выраженной гипертрофии, ритмах из желудочков и т.д. В этих случаях для выявления острого события применяются специальные критерии. * Sgarbossa et al., критерии при БЛНПГ (1996)

Ранняя стадия окклюзии или динамическая (интермиттирующая) окклюзия

ЭКГ может «не успеть» показать подъём ST в момент записи.

Почему STEMI возможен без полной острой окклюзии

Подъём ST — это электрофизиологический маркер выраженной трансмуральной ишемии, но он не гарантирует, что просвет артерии полностью закрыт именно сейчас. Возможны:

* неполная окклюзия/тяжёлый стеноз с выраженным спазмом; * быстрое спонтанное восстановление кровотока к моменту ЭКГ; * другие состояния, имитирующие подъём ST (перикардит, ранняя реполяризация и др.), которые требуют дифференциальной диагностики.

Сводная таблица: что измеряет каждая парадигма

| Парадигма | Что она пытается «поймать» | Сильная сторона | Главная слабость для неотложных решений | |---|---|---|---| | Q/не‑Q | След некроза на ЭКГ, часто связанный с объёмом | Прогностическая грубая стратификация в дореперфузионную эпоху | Поздний и ретроспективный маркер, плохо отражает текущую окклюзию | | STEMI/NSTEMI | ЭКГ‑паттерн, связанный с пользой немедленной реперфузии | Быстрый триаж и организация «времязависимой» помощи | Подъём ST — суррогат: часть окклюзий попадает в NSTEMI, часть STEMI не является полной окклюзией |

Переход к логике OMI/NOMI как следующий шаг (краткое введение)

Раз парадигма STEMI/NSTEMI не идеально совпадает с наличием острой окклюзии, появилась идея классифицировать пациентов по механизму:

OMI (Occlusion MI) — инфаркт, вызванный острой окклюзией (или функциональным эквивалентом окклюзии), где нужна немедленная* реперфузия. * NOMI (Non‑Occlusion MI) — инфаркт без острой окклюзии, где тактика чаще строится на оценке риска, динамике тропонинов, симптомах, ЭхоКГ и результатах ангиографии.

Смысл OMI/NOMI — попытаться приблизить диагностическую модель к реальному механизму и тем самым снизить пропуск окклюзий среди NSTEMI и уменьшить «ошибочную» активацию катетеризационной лаборатории у пациентов без окклюзии.

В следующих материалах курса эта парадигма будет разобрана подробнее: какие ЭКГ‑паттерны считаются «эквивалентами STEMI», почему одних миллиметров ST недостаточно и как строится практический алгоритм распознавания OMI.

Ключевые выводы

Q/не‑Q описывает в основном результат* (сформировавшийся некроз), поэтому плохо подходит для сверхранних решений. * STEMI/NSTEMI возник как практический ответ на появление реперфузии: нужен был быстрый критерий, коррелирующий с пользой немедленного лечения. STEMI/NSTEMI — полезная организационная модель, но это не точная модель острой окклюзии*: часть OMI «прячется» в NSTEMI, а подъём ST не всегда означает текущую полную окклюзию. * OMI/NOMI предлагает сдвиг от «паттерна ST» к «вероятности окклюзии по совокупности данных», что потенциально повышает точность распознавания времени‑критичных пациентов.

Источники

* GISSI-1 (Lancet, 1986) — Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction * ISIS-2 (Lancet, 1988) — Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction * FTT Collaborative Group (Lancet, 1994) — Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials * ESC/ACC (2000) — Myocardial infarction redefined * Thygesen et al. (2018) — Fourth Universal Definition of Myocardial Infarction * de Winter et al. (2008) — A new ECG sign of proximal LAD occlusion * Sgarbossa et al. (1996) — ECG diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block

Which studies shaped STEMI/NSTEMI: thrombolysis, ECG criteria, and reperfusion strategies

How this fits the course narrative

In the previous article, we traced why cardiology moved from the Q/non‑Q framework (a mostly retrospective description of infarct size) toward the STEMI/NSTEMI framework (a time-critical triage model).

This article answers the next logical question: which bodies of evidence made “ST-elevation” the practical trigger for immediate reperfusion, and how clinical trials, meta-analyses, and workflow considerations turned STEMI/NSTEMI into a dominant decision pathway.

!Timeline of the evidence that transformed MI care into a STEMI/NSTEMI triage model

The key clinical problem trials needed to solve

Reperfusion therapy (first fibrinolysis, later primary PCI) is most beneficial when delivered early and to the right patients. Trialists and guideline writers needed a bedside rule that was:

Fast (no waiting for biomarkers).

Reproducible across hospitals and ambulance systems.

Predictive of a patient group that consistently benefits from immediate reperfusion.

The 12‑lead ECG—specifically ST‑segment elevation—became that rule not because it is a perfect marker of coronary occlusion, but because it was a workable selection tool for reperfusion trials and emergency systems.

Thrombolysis trials: how ST elevation became the “right population”

Why fibrinolysis trials focused on ECG patterns

Fibrinolytics target coronary thrombus. Early randomized trials enrolled patients with suspected acute MI using combinations of:

Ischemic symptoms.

ECG patterns (often ST elevation).

Early biomarkers of the era (less sensitive than modern troponins).

As datasets grew, it became clear that the net clinical benefit of fibrinolysis was strongest and most consistent in patients with ST elevation (and in some analyses, new bundle-branch block patterns were also treated as high-risk equivalents, later refined).

Landmark trials that built confidence in immediate pharmacologic reperfusion

The following trials did not “invent” STEMI, but they established a critical idea: there exists an ECG-defined group in whom immediate reperfusion saves lives.

GISSI-1 (1986) showed mortality reduction with streptokinase in acute MI, supporting routine early reperfusion in appropriate patients. GISSI-1 (Lancet, 1986) on PubMed

ISIS-2 (1988) demonstrated that both streptokinase and aspirin reduce vascular mortality, with additive benefit—accelerating adoption of reperfusion and antiplatelet therapy as early standards. ISIS-2 (Lancet, 1988) on PubMed

The synthesis step: meta-analysis and the consolidation of ECG-based selection

A major consolidation point was the FTT Collaborative Group overview, which aggregated randomized fibrinolysis trials and evaluated outcomes across ECG presentations.

It supported that patients with ST elevation (and certain high-risk ECG patterns considered similar at the time) derive the clearest mortality benefit from fibrinolysis.

It also helped crystallize the idea that not every “suspected MI” presentation benefits equally from immediate lysis.

FTT Collaborative Group overview (Lancet, 1994) on PubMed

Why this mattered for the STEMI/NSTEMI split

Trials needed a clear enrollment rule.

ST elevation was a visible, immediate marker correlated with large areas of acute transmural ischemia.

Systems of care (ED triage, ambulance protocols) could operationalize it.

The result was a pragmatic dichotomy: ST elevation → immediate reperfusion pathway.

Making “ST elevation” operational: ECG criteria evolved to reduce ambiguity

Once the ECG became a gatekeeper for urgent reperfusion, clinicians had to answer: what counts as diagnostic ST elevation?

The criteria were operationalized in guidelines to balance:

Sensitivity (not missing patients who benefit).

Specificity (not flooding cath labs or giving lytics to mimics).

Contemporary guideline definitions specify ST elevation at the J point in contiguous leads with age- and sex-specific thresholds (e.g., higher cutoffs in V2–V3 in certain groups). These thresholds are not purely physiologic truths; they are pragmatic rules refined by population data and safety considerations.

A representative modern synthesis is the ESC STEMI guideline document:

2017 ESC Guidelines for STEMI (European Heart Journal, 2018) on PubMed

Special ECG situations forced additional criteria

Some baseline ECG patterns distort ST segments and required dedicated diagnostic frameworks. A classic example is suspected acute MI with left bundle branch block (LBBB), where Sgarbossa criteria were proposed to identify infarction patterns.

Sgarbossa et al. (1996) on PubMed

This line of work reinforced a broader point: even within the STEMI/NSTEMI framework, clinicians often need pattern recognition beyond millimeters of ST elevation.

The PCI era: studies that shifted “best reperfusion” from lytics to the cath lab

Thrombolysis established the principle of urgent reperfusion. Primary PCI studies then reshaped the preferred method of reperfusion.

Why primary PCI changed the system-level logic

Primary PCI offered:

Higher rates of infarct-artery patency.

Lower risk of intracranial hemorrhage than fibrinolytics.

A direct anatomic answer (occlusion vs non-occlusion) once angiography is performed.

However, it required logistics (24/7 cath lab, rapid transfer), so evidence had to show meaningful outcome advantages.

Influential comparisons: primary PCI vs thrombolysis

Two highly influential evidence nodes:

A large quantitative review/meta-analysis found improved outcomes with primary angioplasty compared with thrombolysis when performed promptly. Keeley et al. (Lancet, 2003) on PubMed

A randomized strategy trial showed better outcomes with transfer for primary PCI compared to on-site fibrinolysis in a system capable of timely transport. DANAMI-2 (NEJM, 2003) on PubMed

How this reinforced STEMI/NSTEMI

STEMI became the activation label for a reperfusion machine: cath lab mobilization, transfer protocols, door-to-balloon metrics.

NSTEMI was increasingly managed with risk stratification and early (but not necessarily immediate) invasive strategies.

Troponins and the expansion of NSTEMI: a parallel evidence stream

While reperfusion trials shaped the “STEMI = immediate” pathway, biomarkers reshaped the definition of infarction itself.

More sensitive troponin assays reclassified many patients previously labeled unstable angina into NSTEMI, because small necroses became detectable.

ESC/ACC consensus “Myocardial infarction redefined” (2000) on PubMed

Fourth Universal Definition of MI (2018) on PubMed

This made NSTEMI a larger and more heterogeneous group, spanning:

Small infarcts with partial thrombosis.

Demand ischemia with injury patterns.

And importantly for later course modules: some cases of acute coronary occlusion without classic ST elevation.

What the STEMI/NSTEMI paradigm ultimately became

By the mid-2000s, STEMI/NSTEMI functioned as a combined model of:

Diagnosis (ECG pattern + biomarkers for MI classification).

Therapeutic urgency (STEMI = activate immediate reperfusion pathway).

System design (prehospital ECG, STEMI networks, cath lab readiness).

This is why the paradigm proved so durable: it aligned clinical trials, guidelines, and hospital workflow.

Why this evidence base also planted the seeds for OMI/NOMI

The very success of STEMI systems revealed a structural limitation:

Trials and protocols optimized speed using a simple ECG gate.

But ST elevation is a surrogate for the mechanism that truly matters in time-critical cases: acute coronary occlusion.

As clinicians recognized reproducible ECG patterns of occlusion without classic ST elevation (for example the de Winter pattern), pressure grew for a mechanism-centered paradigm.

de Winter et al. (2008) on PubMed

This sets up the course transition: from “ST elevation = emergent” toward OMI/NOMI, where the goal is to identify occlusion using the whole ECG + clinical context + bedside imaging, rather than relying on a single threshold.

Summary table: which evidence did what

| Evidence stream | Representative studies | Main contribution to STEMI/NSTEMI | Practical consequence | |---|---|---|---| | Fibrinolysis RCTs | GISSI-1, ISIS-2 | Established mortality benefit of early reperfusion in selected acute MI patients | Need for rapid bedside selection | | Fibrinolysis meta-analysis | FTT overview | Consolidated that benefit is strongest in ST-elevation presentations | ST elevation becomes a key “treatment trigger” | | ECG special-case criteria | Sgarbossa (LBBB) | Addressed diagnostic uncertainty when baseline ECG confounds ST segments | “STEMI-equivalents” and pattern-based interpretation | | Primary PCI evidence | Keeley meta-analysis, DANAMI-2 | Primary PCI superior to lytics when timely and feasible | STEMI networks, transfers, door-to-balloon culture | | Biomarker redefinition | ESC/ACC 2000; Universal Definition 2018 | Troponin-based definition expands NSTEMI and formalizes MI diagnosis | NSTEMI becomes broader, increasing heterogeneity |

Key takeaways

STEMI/NSTEMI was shaped less by theory and more by trial enrollment logic and operational needs.

Thrombolysis trials and especially the FTT overview helped cement ST elevation as the clearest ECG marker of a group that benefits from immediate reperfusion.

Primary PCI trials and meta-analyses shifted the preferred reperfusion method while reinforcing the same fast ECG-based activation model.

Troponins expanded NSTEMI and increased heterogeneity—one reason why later clinicians sought an occlusion-centered framework (OMI/NOMI).

Sources

GISSI-1 (Lancet, 1986) on PubMed

ISIS-2 (Lancet, 1988) on PubMed

FTT Collaborative Group overview (Lancet, 1994) on PubMed

Sgarbossa et al. (1996) on PubMed

ESC/ACC “Myocardial infarction redefined” (2000) on PubMed

Keeley et al. Primary angioplasty vs thrombolysis meta-analysis (Lancet, 2003) on PubMed

DANAMI-2 (NEJM, 2003) on PubMed

de Winter et al. (2008) on PubMed

Fourth Universal Definition of MI (2018) on PubMed

2017 ESC Guidelines for STEMI (European Heart Journal, 2018) on PubMed

Why STEMI/NSTEMI is not the same as “occlusion/no occlusion”: pathophysiology and the limits of an ECG-only approach

Where this article fits in the course

In the previous articles, we followed the historical shift:

From Q/non-Q MI (a mostly retrospective description of necrosis size)

To STEMI/NSTEMI (a time-critical triage model designed to trigger immediate reperfusion)

This article explains the key conceptual gap that emerged once STEMI systems became highly efficient: ST-segment elevation is a useful workflow trigger, but it is not a reliable one-to-one marker of acute coronary occlusion.

!Side-by-side comparison of the decision logic behind STEMI/NSTEMI versus an occlusion-centered approach.

Terms we must separate

Myocardial infarction (MI)

MI means myocardial necrosis (cell death) caused by ischemia, typically diagnosed using:

Symptoms or ischemic equivalents

Dynamic ECG changes

Biomarkers (especially troponin)

Imaging evidence of new loss of viable myocardium

A widely used framework is the Fourth Universal Definition of MI.

Thygesen et al. Fourth Universal Definition of MI (2018)

Acute coronary occlusion

An acute coronary occlusion is a sudden closure (or near-complete functional closure) of a coronary artery that produces ongoing severe ischemia. Clinically, this is the scenario where:

Benefit from reperfusion is strongly time-dependent

Delay increases infarct size and worsens outcomes

STEMI/NSTEMI

STEMI/NSTEMI is primarily an ECG-based triage label:

STEMI: meets guideline ST-elevation criteria and usually triggers immediate reperfusion pathways

NSTEMI: does not meet ST-elevation criteria and usually goes to risk-based early invasive strategies

This system was shaped by thrombolysis and PCI-era trial logistics, not by a claim that ST elevation perfectly equals occlusion.

FTT Collaborative Group overview (1994)

2017 ESC Guidelines for STEMI (2018)

What ST-segment elevation actually represents (pathophysiology in plain language)

ST-segment shifts reflect injury currents created by voltage differences between:

Relatively ischemic myocardium

Relatively non-ischemic myocardium

A helpful mental model:

Severe transmural ischemia (involving the full thickness of the wall) often produces ST elevation in leads facing the injured territory

Predominantly subendocardial ischemia (inner layer) often produces ST depression and/or T-wave changes

But clinical reality is messier because ECG is influenced by:

The occluded artery and the size of the threatened territory

Collateral flow and residual (partial) flow

Time from occlusion to ECG acquisition

Which leads “see” the injured region (12-lead ECG is a limited sampling)

Baseline conduction and repolarization patterns

Why an acute occlusion can present without diagnostic ST elevation

The key point: a patient can have an occluded artery and still fail to meet STEMI criteria. Several mechanisms explain this.

The territory may be “electrically hidden” on the standard 12-lead ECG

The classic example is posterior MI.

The posterior wall is not directly visualized by standard precordial leads.

Instead of posterior ST elevation, the 12-lead often shows reciprocal ST depression in V1–V3 (a “mirror image” effect).

Adding posterior leads (V7–V9) may reveal the ST elevation.

Practical consequence: a true occlusion MI can be mis-triaged as NSTEMI unless posterior involvement is recognized.

Occlusion can produce patterns that are not counted as “STEMI” by millimeter thresholds

Some reproducible occlusion patterns do not meet classic STEMI criteria, for example:

de Winter pattern (often proximal LAD occlusion): upsloping ST depression with tall, symmetric T waves in anterior leads.

de Winter et al. (2008)

This is one reason clinicians talk about “STEMI equivalents”: the mechanism can be the same, while the ECG signature differs.

Baseline ECG abnormalities can mask or distort ST segments

When depolarization is abnormal, repolarization becomes difficult to interpret, and the usual STEMI thresholds are unreliable. High-yield examples:

Left bundle branch block (LBBB)

Ventricular paced rhythm

Marked left ventricular hypertrophy with secondary ST-T changes

For LBBB, special criteria were proposed (Sgarbossa) because standard ST-elevation rules are not applicable.

Sgarbossa et al. (1996)

Timing matters: the ECG is a snapshot of a dynamic process

An occlusion event can evolve through stages:

Early phase: hyperacute T waves may precede diagnostic ST elevation

Intermediate phase: ST elevation may become clearer

Later phase: ST elevation can normalize even while injury continues, especially with partial reperfusion

If the ECG is recorded at the “wrong” time, classic STEMI criteria may not be present despite ongoing occlusion.

Collateral flow and partial flow can blunt ST elevation despite a critical culprit lesion

Two patients with the same occluded artery can have different surface ECGs depending on:

Collateral circulation

Residual antegrade flow

Preconditioning and microvascular factors

In practice, some occlusions behave more like a “subendocardial” ECG phenotype, even when the angiographic culprit is time-critical.

Why diagnostic ST elevation does not guarantee an acute persistent occlusion

The reverse mismatch is also common: ST elevation can appear without a current complete thrombotic occlusion.

The artery may have reopened before the ECG (spontaneous reperfusion)

A patient can have:

Transient occlusion with ST elevation

Spontaneous lysis or partial reopening

At the moment of angiography, the artery may not be fully occluded, even though the presentation was time-critical.

ST elevation can reflect severe ischemia without complete occlusion

Examples include:

Critical subtotal stenosis with intense vasoconstriction

Dynamic plaque/thrombus with intermittent flow limitation

This matters because the “mechanism” is not binary; flow can vary minute-to-minute.

ST elevation has non-ischemic mimics

Not all ST elevation is acute MI. Important mimics:

Acute pericarditis

Early repolarization

Left ventricular aneurysm (old MI with persistent ST elevation)

Brugada pattern

Hyperkalemia and other metabolic states

This is why STEMI systems emphasize rapid ECG interpretation expertise and clinical correlation, even though the workflow trigger is “simple.”

The operational nature of STEMI criteria

Guideline STEMI thresholds (J-point elevation in contiguous leads with specific cutoffs) are best understood as:

A practical selection rule that worked well for large groups in reperfusion trials

A compromise between sensitivity and specificity

They were never a physiologic promise that:

STEMI equals occlusion in 100% of cases

NSTEMI equals non-occlusion in 100% of cases

This is the core reason the STEMI/NSTEMI dichotomy can misclassify mechanism.

Clinical consequence: the “NSTEMI bucket” contains some time-critical occlusions

As troponins became more sensitive, NSTEMI expanded and became heterogeneous, mixing:

Small infarcts

Supply-demand mismatch injury

Microvascular etiologies

n- And importantly: occlusion MIs that do not meet STEMI criteria

Thygesen et al. Fourth Universal Definition of MI (2018)

From a workflow standpoint, this creates a risk:

If “NSTEMI” is interpreted as “not an occlusion,” some patients who need immediate reperfusion may be delayed.

How this sets up the OMI/NOMI paradigm

The OMI/NOMI paradigm (covered in depth later in the course) starts from a different clinical question:

Not “Is there ST elevation?”

But “Is there evidence of acute coronary occlusion or a functional equivalent requiring immediate reperfusion?”

OMI/NOMI is not “anti-ECG.” It is more ECG, not less:

It treats the ECG as a pattern-recognition tool, not a millimeter checklist

It integrates symptoms, ECG evolution, bedside echo for wall-motion abnormalities, and risk context

The goal is to better match triage to mechanism and urgency, reducing:

Missed occlusions hiding in NSTEMI

Unnecessary cath lab activations for non-occlusive STEMI mimics

A compact comparison

| Question you are trying to answer | STEMI/NSTEMI approach | Occlusion-centered (OMI/NOMI) goal | |---|---|---| | Who needs immediate reperfusion? | Uses ST elevation criteria as the main trigger | Uses total evidence for acute occlusion (ECG patterns, evolution, echo, context) | | Main strength | Fast, scalable, highly operational | Better alignment with mechanism (occlusion) | | Main weakness | ST elevation is an imperfect surrogate | Requires greater ECG expertise and integration of data |

Key takeaways

STEMI/NSTEMI is a highly effective system design and triage model, built around ST elevation as a practical trigger for reperfusion.

Acute coronary occlusion can occur without diagnostic ST elevation, due to territory visibility (posterior MI), non-classic occlusion patterns (de Winter), baseline conduction patterns (LBBB/pacing), timing, and collateral flow.

ST elevation does not guarantee persistent complete occlusion and has important non-ischemic mimics.

The mismatch between “ST elevation” and “occlusion” is the main reason the course transitions toward an OMI/NOMI mechanism-centered framework.

Sources

FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction (1994)

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (2018)

Thygesen et al. Fourth Universal Definition of Myocardial Infarction (2018)

de Winter et al. A new ECG sign of proximal LAD occlusion (2008)

Sgarbossa et al. ECG diagnosis of evolving MI in the presence of LBBB (1996)

False “NSTEMI” in Occlusion: ECG patterns and clinical miss scenarios of acute coronary occlusion

Why this article exists in the course

In the previous modules, we established three linked ideas:

Q/non‑Q MI described infarct after the fact (often too late for time‑critical decisions).

STEMI/NSTEMI became a powerful workflow because ST‑segment elevation was a practical trigger for immediate reperfusion in major reperfusion trials.

The core limitation: STEMI/NSTEMI is not the same as “occlusion / no occlusion.” ST elevation is a surrogate, not a mechanism.

This article zooms in on the most dangerous consequence of that mismatch: patients with acute coronary occlusion who do not meet STEMI criteria and are therefore labeled “NSTEMI” and delayed. In an occlusion-centered vocabulary, these are often OMI (Occlusion MI) hiding inside the NSTEMI bucket.

> The goal is not to “abolish NSTEMI,” but to recognize when the NSTEMI label becomes a trap for an occlusion that still needs immediate reperfusion.

!Two decision logics: threshold-based STEMI activation versus mechanism-based OMI detection.

What “false NSTEMI” means (definition in plain language)

A false NSTEMI is not a laboratory mistake. It is a triage misclassification:

The patient has acute coronary occlusion (or a functional equivalent) causing ongoing ischemia.

The ECG does not meet guideline STEMI millimeter criteria at the time it is recorded.

The patient is managed as NSTEMI (often “early but not immediate” angiography), and reperfusion is delayed.

In OMI/NOMI terms:

Many “false NSTEMI” cases are OMI.

The harm comes from time: ongoing occlusion means expanding irreversible injury.

A key context point: the universal definition of MI is biomarker-based and clinical; it does not claim that NSTEMI equals non-occlusion.

Fourth Universal Definition of Myocardial Infarction (2018)

Why occlusion can fail STEMI criteria

Several mechanisms make an occlusion “invisible” to a single 12‑lead snapshot and to millimeter thresholds:

The infarct territory is under-sampled by the standard 12 leads (posterior wall is the classic example).

The ECG pattern is an occlusion pattern but not a STEMI pattern (pattern recognition problem).

Baseline conduction/repolarization abnormalities distort ST segments (interpretation problem).

The event is dynamic (timing problem): the ECG is recorded before classic ST elevation appears, or after transient reperfusion.

This is the conceptual bridge to OMI/NOMI: if the clinical question is occlusion, the ECG must be read as a pattern over time, not as a single threshold.

FTT Collaborative Group overview (1994)

2017 ESC STEMI guidelines (published 2018)

High-yield ECG patterns where occlusion often gets mislabeled as “NSTEMI”

The point of this section is not to memorize rare curiosities, but to recognize repeatable scenarios where strict STEMI criteria underperform.

Posterior OMI (often LCx or RCA): the “hidden wall” problem

What the 12‑lead often shows

ST depression in V1–V3 (often horizontal or downsloping)

Relatively tall R waves in V1–V3 (a “mirror” of posterior Q)

Prominent upright T waves in V1–V3 can occur

Why it is missed

Posterior ST elevation is not directly seen by standard precordial leads.

Clinicians may interpret V1–V3 ST depression as “subendocardial ischemia” and default to NSTEMI pathways.

What reduces misses

Recording posterior leads V7–V9 when V1–V3 ST depression suggests a posterior event.

de Winter pattern (classically proximal LAD occlusion): “occlusion without ST elevation”

Typical features (descriptive, not dependent on a single millimeter cutoff)

Up-sloping ST depression at the J point in the anterior leads

Tall, symmetric T waves in the precordial leads

Often slight ST elevation in aVR

Why it is missed

It fails classic STEMI criteria, so it can be labeled NSTEMI despite representing a time-critical LAD culprit.

de Winter et al. (2008)

LBBB or ventricular paced rhythm: “STEMI rules don’t apply”

The core issue

In LBBB and pacing, secondary ST-T changes are expected, so standard STEMI millimeter thresholds become unreliable.

Why occlusion gets mislabeled NSTEMI

If clinicians interpret “no diagnostic ST elevation” as reassurance, occlusion can be delayed.

What improves detection

Using dedicated criteria (the classic reference is Sgarbossa) and combining them with clinical instability and adjuncts like bedside echo.

Sgarbossa et al. (1996)

Diffuse ST depression with ST elevation in aVR: high-risk ischemia that may represent an occlusion mechanism

What you may see

Widespread ST depression in multiple leads

ST elevation in aVR (sometimes also V1)

Why it is commonly triaged as NSTEMI

It does not match the “contiguous lead ST elevation” STEMI template.

Why it matters

This pattern can signal a very high-risk coronary anatomy or severe supply limitation, where delay can be catastrophic.

Practical take: treat this as a do-not-ignore pattern requiring urgent senior review, serial ECGs, and rapid escalation when paired with ongoing symptoms or hemodynamic compromise.

Subtle anterior OMI: “below threshold” ST elevation plus supportive clues

What makes it dangerous

Early LAD occlusion can present with very small ST elevation (below STEMI cutoffs), hyperacute T waves, and reciprocal changes.

Supportive clues that should raise suspicion

Hyperacute (broad, tall, symmetric) T waves in the anterior leads

Reciprocal ST depression in inferior leads

Rapid ECG evolution on repeat tracings

This is a classic example of why OMI reading emphasizes serial ECGs and comparisons, not a single snapshot.

Transient occlusion or spontaneous reperfusion: “the STEMI already happened (but you didn’t see it)”

What happens

The artery occludes, the patient has a STEMI physiology, then partial reperfusion occurs.

By the time the ECG is recorded, ST elevation may have normalized or transformed.

How it becomes a false NSTEMI

The patient is triaged as NSTEMI because the “STEMI moment” was missed.

What helps

Early prehospital ECGs, repeat ECGs in the ED, and careful history of symptom onset and dynamics.

Clinical scenarios that amplify the risk of missing an occlusion inside “NSTEMI”

ECG patterns do not exist in isolation. The following clinical contexts should lower your threshold to suspect OMI even when STEMI criteria are not met:

Ongoing or recurrent ischemic pain, especially if not responding to initial therapy.

Hemodynamic compromise (hypotension, pulmonary edema) or malignant arrhythmias.

A new regional wall-motion abnormality on bedside echo that fits a coronary territory.

Disproportionate clinical severity compared with the apparent ECG (for example, a patient who looks like a STEMI clinically but “only” has ST depression).

ECG confounders (LBBB, pacing, marked LVH) where STEMI criteria are known to be unreliable.

In other words: “NSTEMI” should never be interpreted as “not time-critical” without checking whether an occlusion mechanism is plausible.

A practical, OMI-oriented reading approach when the label says NSTEMI

This is a structured way to reduce false reassurance from “no STEMI criteria.”

Start with the question, not the category

- Ask: Is there evidence of acute coronary occlusion or a functional equivalent needing immediate reperfusion?

Read the ECG as a pattern

- Look specifically for posterior MI clues, de Winter pattern, diffuse ST depression with aVR elevation, hyperacute T waves, and concordant changes in confounder rhythms.

Repeat the ECG early and often when symptoms persist

- Serial ECGs convert a static threshold into a dynamic diagnostic tool.

Add leads when the territory is not well seen

- Posterior leads V7–V9 when V1–V3 show suspicious ST depression.

Use bedside echo as a mechanism test

- A new focal wall-motion abnormality strongly supports an acute coronary process and can justify urgent escalation even when the ECG is nondiagnostic.

Escalate decisively when high-risk features cluster

- The OMI mindset is about preventing time loss in the subset of “NSTEMI” patients who are actually occlusions.

Summary table: patterns, pitfalls, and the “next best step”

| Scenario that may be triaged as NSTEMI | What the ECG often shows | Typical mechanism | Why STEMI criteria may fail | What reduces misses | |---|---|---|---|---| | Posterior OMI | V1–V3 ST depression, tall R | LCx/RCA culprit | Posterior wall not directly visualized | Record V7–V9; interpret mirror changes | | de Winter pattern | Up-sloping anterior ST depression + tall symmetric T | Proximal LAD occlusion | No classic contiguous ST elevation | Recognize pattern; treat as OMI | | LBBB / paced rhythm | “Uninterpretable” ST shifts | Any culprit occlusion | Baseline repolarization abnormal | Use dedicated criteria + clinical context + echo | | Diffuse ST depression + aVR elevation | Widespread ST depression, aVR ST elevation | Severe supply limitation / high-risk anatomy, sometimes occlusion | Doesn’t fit STEMI template | Urgent reassessment, serial ECGs, rapid escalation | | Subtle anterior OMI | Minimal STE, hyperacute T, reciprocal changes | Early LAD occlusion | Below guideline thresholds | Serial ECGs; compare to prior; pattern recognition | | Transient occlusion | Evolving or resolving changes | Intermittent occlusion/reperfusion | Single ECG may miss the peak | Early ECG capture; repeat ECGs |

How this supports the shift to OMI/NOMI

STEMI/NSTEMI remains essential for system organization, but its categorical trigger can misroute a subset of occlusions into “NSTEMI pathways.” OMI/NOMI aims to:

Increase sensitivity for time-critical occlusion by expanding ECG interpretation beyond ST-elevation millimeters.

Integrate serial ECGs, additional leads, bedside imaging, and clinical instability.

In the next course materials, we will build this into a practical OMI/NOMI framework: how to operationalize occlusion suspicion without turning every NSTEMI into an emergent cath activation.

Sources

FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction (1994)

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (published 2018)

Thygesen et al. Fourth Universal Definition of Myocardial Infarction (2018)

de Winter et al. A new ECG sign of proximal LAD occlusion (2008)

Sgarbossa et al. ECG diagnosis of evolving MI in the presence of left bundle-branch block (1996)

Парадигма OMI/NOMI: определения, логика и критерии распознавания окклюзионного ИМ

Контекст: почему после STEMI/NSTEMI возникла потребность в новой логике

В предыдущих статьях курса мы последовательно пришли к ключевому разрыву:

STEMI/NSTEMI исторически стал маршрутизационной моделью: подъём ST использовался как быстрый «триггер» немедленной реперфузии, потому что именно так были устроены исследования тромболизиса и затем системы первичного ЧКВ.

Однако STEMI/NSTEMI не является точной моделью механизма: острая коронарная окклюзия может быть без диагностического подъёма ST, а подъём ST возможен без персистирующей полной окклюзии и имеет мимики.

Парадигма OMI/NOMI — попытка вернуть диагностику к клиническому вопросу, который реально определяет срочность:

есть ли сейчас острая окклюзия (или функциональный эквивалент окклюзии), где промедление приводит к потере миокарда?

!Схема сравнения порогового подхода STEMI и механизм-ориентированного подхода OMI.

Определения: что именно означают OMI и NOMI

Базовые термины, которые нельзя смешивать

Инфаркт миокарда (ИМ) — это некроз миокарда из-за ишемии, обычно подтверждаемый динамикой тропонина и клиническими/ЭКГ/визуализационными признаками.

- Современная рамка: Fourth Universal Definition of Myocardial Infarction (2018)

Острая коронарная окклюзия — это внезапное прекращение или почти полное прекращение кровотока по коронарной артерии (иногда интермиттирующее), при котором исход критически зависит от времени до реперфузии.

OMI (Occlusion MI)

OMI — инфаркт, при котором клиническая картина и данные (прежде всего ЭКГ и динамика) указывают на острую окклюзию коронарной артерии или функционально эквивалентное состояние, требующее немедленной реперфузии.

Важно: OMI — не «новый диагноз вместо ИМ», а механизм-ориентированная категория срочности.

NOMI (Non-Occlusion MI)

NOMI — инфаркт без признаков острой окклюзии как текущего механизма события (например, неполная тромбоз/нестабильная бляшка без полной окклюзии, микрососудистые причины, иные сценарии ИМ), где тактика чаще строится на:

оценке риска,

динамике симптомов и тропонина,

планировании ранней (но не обязательно немедленной) ангиографии.

Логика OMI/NOMI: что является «мишенью» диагностики

Парадигма OMI/NOMI меняет главный вопрос врача в первые минуты:

вместо «есть ли подъём ST по критериям?»

на «есть ли признаки окклюзии, при которой нельзя терять время?»

Практическая цель — уменьшить две системные ошибки STEMI/NSTEMI:

ложное успокоение: окклюзия «прячется» в NSTEMI и реперфузия задерживается;

ложная активация: подъём ST связан с мимиком ИМ (перикардит, ранняя реполяризация и т.д.).

При этом OMI/NOMI не отменяет STEMI/NSTEMI как организационную модель. OMI/NOMI добавляет надстройку клинического смысла поверх порогов.

Принцип распознавания OMI: «ЭКГ как паттерн, а не линейка миллиметров»

STEMI-критерии полезны как быстрые правила, но в OMI-подходе ЭКГ читается иначе:

ищется узнаваемый паттерн окклюзии;

учитываются реципрокные изменения;

обязательно оценивается динамика на серийных ЭКГ;

учитываются ситуации, где обычные правила не работают (например, БЛНПГ).

Историческая причина, почему пороги ST так закрепились в практике, обсуждалась ранее: так были построены исследования реперфузии и рекомендации.

FTT Collaborative Group (1994)

2017 ESC STEMI Guidelines (2018)

Критерии распознавания OMI: что должно заставить думать об окклюзии немедленно

Ниже — практический список высокозначимых сигналов, когда даже при формальном отсутствии STEMI-критериев следует рассматривать OMI.

ЭКГ-паттерны окклюзии, которые часто не проходят «миллиметровые» пороги STEMI

Задний (постериорный) инфаркт

- Часто выглядит как депрессия ST в V1–V3 (зеркальный феномен), иногда с относительно высокими R в V1–V3. - Если не думать о задней стенке, это легко уходит в «NSTEMI».

Паттерн de Winter

- Часто соответствует окклюзии проксимальной ПНА, но без классического подъёма ST. - Ключевые признаки: восходящая депрессия ST в прекардиальных отведениях на уровне J-точки и высокие симметричные T. - Источник: de Winter et al. (2008)

Субтильный передний OMI

- Минимальный подъём ST (ниже порога) плюс поддерживающие признаки: гиперакутные T, реципрокная депрессия ST в нижних отведениях, быстрая эволюция на повторных ЭКГ.

Диффузная депрессия ST с подъёмом ST в aVR

- Это не «типичный STEMI», но часто означает крайне высокорисковую ишемию. - В OMI-логике это паттерн, который нельзя обесценивать: требуется срочная оценка тяжести состояния и быстрая эскалация при продолжающихся симптомах.

Ситуации, где «обычные STEMI-правила» непригодны

Блокада левой ножки пучка Гиса (БЛНПГ)

- Стандартные пороги ST теряют надёжность из-за вторичных изменений реполяризации. - Источник классических диагностических подходов: Sgarbossa et al. (1996)

Желудочковая стимуляция

- Проблема аналогична БЛНПГ: реполяризация вторично изменена, поэтому «нет подъёма ST» не означает «нет окклюзии».

Клинические признаки, усиливающие вероятность OMI даже при неубедительной ЭКГ

продолжающаяся или рецидивирующая ишемическая боль;

гемодинамическая нестабильность (гипотензия, отёк лёгких) или электрическая нестабильность (желудочковые аритмии);

выраженная вегетативная симптоматика и несоответствие тяжести состояния «скромной» ЭКГ;

новый локальный дефект сократимости на ЭхоКГ, соответствующий коронарному бассейну.

Инструменты, которые делают OMI-подход практичным, а не абстрактным

Серийные ЭКГ как обязательный элемент

OMI может быть динамическим процессом (интермиттирующая окклюзия, ранняя стадия, спонтанная реперфузия). Поэтому один снимок ЭКГ часто недостаточен.

Практический принцип:

если симптомы сохраняются или возвращаются, ЭКГ нужно повторять, а не «ждать тропонин».

Дополнительные отведения, когда зона плохо видна

Стандартные 12 отведений не идеально «видят» заднюю стенку. В клинической работе это означает:

при подозрении на задний инфаркт важно активно искать подтверждение (например, задние отведения), а не автоматически относить к NSTEMI.

ЭхоКГ у постели как тест механизма

В парадигме OMI bedside ЭхоКГ выполняет роль ускорителя принятия решения:

новый регионарный гипокинез поддерживает ишемический механизм;

при сомнительной ЭКГ и тяжёлом пациенте это может быть тем аргументом, который оправдывает немедленную инвазивную стратегию.

Важно: нормальная ЭхоКГ не всегда исключает ранний OMI, но патологическая ЭхоКГ часто значительно повышает вероятность.

Мини-алгоритм OMI/NOMI для неотложной практики

Ниже — концептуальный алгоритм, который можно применять поверх стандартных протоколов.

Оценить симптомы и гемодинамику

- если есть нестабильность или продолжающаяся боль, порог подозрения OMI снижается.

Считать ЭКГ не только по порогам STEMI, но и по паттернам

- задний инфаркт (зеркальные изменения в V1–V3), de Winter, гиперакутные T, реципрокные изменения, диффузная депрессия ST + aVR.

Сделать серийную ЭКГ при сохранении симптомов

- динамика часто превращает «не STEMI» в очевидную ишемическую эволюцию.

Добавить визуализацию механизма

- bedside ЭхоКГ на новые локальные нарушения сократимости.

Принять решение о срочности инвазивной стратегии

- OMI-подозрение в сочетании с клиникой и поддерживающими данными должно вести к ускорению реперфузии.

Чем OMI/NOMI точнее, чем STEMI/NSTEMI, именно для диагностики острой окклюзии

Точность в OMI/NOMI достигается не одной «волшебной» находкой, а сменой логики:

STEMI/NSTEMI отвечает на вопрос: соответствует ли ЭКГ порогам, пригодным для массового триажа?

OMI/NOMI отвечает на вопрос: насколько вероятна окклюзия как текущий механизм, где время критично?

То есть OMI/NOMI лучше согласуется с клинической реальностью:

часть опасных окклюзий не делает классический STEMI-подъём ST;

часть подъёмов ST не является персистирующей окклюзией и требует дифференциальной диагностики.

Ключевые выводы

OMI/NOMI — механизм- и срочность-ориентированная надстройка над STEMI/NSTEMI: цель — распознать окклюзию, а не только ST-подъём по порогу.

OMI следует подозревать при характерных ЭКГ-паттернах окклюзии (включая не-STEMI-паттерны), при динамике на серийных ЭКГ и при клинической нестабильности.

Практичность OMI-подхода обеспечивают: серийные ЭКГ, дополнительные отведения при «скрытых» территориях, bedside ЭхоКГ.

STEMI/NSTEMI остаётся важным для системной организации, но не должен интерпретироваться как «окклюзия/не окклюзия».

Источники

Thygesen et al. Fourth Universal Definition of Myocardial Infarction (2018)

FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction (1994)

2017 ESC Guidelines for STEMI (European Heart Journal, 2018)

de Winter et al. A new ECG sign of proximal LAD occlusion (2008)

Sgarbossa et al. ECG diagnosis of evolving MI in the presence of LBBB (1996)

Why OMI/NOMI is more accurate for diagnosing acute coronary occlusion: sensitivity/specificity trade-offs and outcomes

How this article connects to previous modules

Earlier in the course we established a chain of reasoning:

Q/non-Q was mainly a retrospective description of infarction.

STEMI/NSTEMI became a powerful workflow because ST-elevation thresholds were a practical trigger for immediate reperfusion in the thrombolysis and PCI eras.

The key mismatch: STEMI/NSTEMI is not the same as occlusion vs non-occlusion, because acute coronary occlusion can occur without meeting STEMI millimeter criteria, and ST elevation can occur without a persistent thrombotic occlusion.

This article answers the next question: if the time-critical problem is acute coronary occlusion, why does an occlusion-centered OMI/NOMI approach tend to be more accurate than the STEMI/NSTEMI threshold approach, and why does that matter for patient outcomes?

!Two decision logics: threshold-based STEMI activation versus evidence-integrating OMI recognition

What “more accurate” means here

Accuracy depends on the target condition.

STEMI/NSTEMI is designed to classify MI presentations by an ECG threshold and guide pathways.

OMI/NOMI is designed to detect the mechanism that makes time matter most: acute coronary occlusion or a functional equivalent requiring immediate reperfusion.

So the comparison in this article is not primarily about diagnosing MI (troponin-based definitions cover that), but about diagnosing occlusion that should not wait.

A modern reference for what “MI” is (regardless of occlusion status) is the Universal Definition framework.

Fourth Universal Definition of Myocardial Infarction (Thygesen et al., 2018)

Sensitivity and specificity in plain language

When your goal is to detect acute coronary occlusion (OMI), two properties matter.

Sensitivity: among patients who truly have an occlusion, how many does the method correctly flag as needing immediate reperfusion.

Specificity: among patients who truly do not have an occlusion, how many does the method correctly avoid sending to an emergent occlusion pathway.

In practice:

Higher sensitivity reduces missed occlusions (false negatives).

Higher specificity reduces unnecessary emergent activations (false positives), including treatment of mimics.

The STEMI threshold strategy historically leans toward specificity, especially because thrombolysis carries serious bleeding risks.

FTT Collaborative Group overview of fibrinolysis trials (1994)

Why STEMI/NSTEMI is inherently limited for detecting occlusion

STEMI criteria were built for operational triage, not mechanism purity

Guideline STEMI criteria are pragmatic cutoffs intended to be fast and reproducible across systems.

2017 ESC Guidelines for STEMI (Ibanez et al., published 2018)

That pragmatism has a cost: a single pattern threshold cannot capture all occlusions because:

Some occlusion territories are under-sampled by the standard 12-lead ECG.

Some occlusions produce reproducible non-classic patterns rather than classic ST elevation.

Baseline conduction patterns distort ST segments (LBBB, pacing), making standard rules unreliable.

Occlusion can be dynamic, and a single ECG is a snapshot.

Examples of occlusion patterns that often fail STEMI millimeter thresholds

These examples matter because they illustrate why OMI detection requires pattern recognition and integration, not only measuring millimeters.

Posterior occlusion MI often presents as ST depression in V1–V3 due to mirror-image effects rather than obvious ST elevation on a standard 12-lead.

The de Winter pattern can indicate proximal LAD occlusion without classic ST elevation.

LBBB or paced rhythm requires dedicated criteria rather than usual STEMI thresholds.

Key foundational sources for these pattern problems:

de Winter et al. A new ECG sign of proximal LAD occlusion (2008)

Sgarbossa et al. ECG diagnosis of MI in LBBB (1996)

What OMI/NOMI changes operationally

OMI/NOMI does not reject ECG thresholds; it changes the question.

STEMI/NSTEMI asks: does this ECG meet the STE cutoff that historically triggered immediate reperfusion pathways?

OMI/NOMI asks: is there evidence of acute occlusion physiology that makes immediate reperfusion time-critical?

In practice, OMI recognition typically expands sensitivity by:

Counting “STEMI equivalents” as occlusion patterns rather than relegating them to NSTEMI.

Using reciprocal changes, lead distribution logic, and evolution over serial ECGs.

Using bedside echo to detect a new regional wall-motion abnormality that supports an acute culprit lesion.

Treating ongoing pain, shock, pulmonary edema, or malignant arrhythmia as “time-is-myocardium multipliers,” even if STE thresholds are not met.

Sensitivity/specificity: what improves and what must be managed

Why OMI/NOMI can increase sensitivity for occlusion

OMI/NOMI increases sensitivity mainly by reducing the false-negative bucket: occlusions hiding inside NSTEMI. It does this by upgrading certain “NSTEMI-looking” ECGs into “likely occlusion” when the total pattern supports it.

High-yield upgrades include:

Posterior OMI suspected from V1–V3 mirror changes and confirmed with posterior leads.

de Winter pattern treated as an occlusion pattern, not a “non-STEMI.”

LBBB and paced rhythms interpreted with dedicated occlusion criteria rather than declaring the ECG “non-diagnostic.”

A practical example of how dedicated criteria improved recognition in LBBB is the evolution from original Sgarbossa criteria to proportional or modified approaches.

Smith et al. Modified Sgarbossa criteria for MI in LBBB (2012)

Why OMI/NOMI does not have to “destroy specificity”

Increasing sensitivity can increase false positives if done naively. OMI/NOMI aims to preserve specificity by using gates:

Requiring coherent territory patterns rather than isolated minor ST changes.

Looking for supportive findings like reciprocal changes and ECG evolution.

Using bedside echo to test for a new focal wall-motion abnormality.

Maintaining a structured differential for ST elevation mimics rather than assuming all STE is occlusion.

In other words, OMI/NOMI is not “activate cath for everyone.” It is “activate cath for those who appear occluded by total evidence, even if STE millimeters do not qualify.”

Why the difference matters: outcomes and the time component

The clinical harm of misclassifying occlusion as “NSTEMI” is delay

If a patient has ongoing occlusion physiology, then routing them through a slower NSTEMI pathway can increase infarct size and complications.

The central biological principle is well supported across reperfusion eras:

Benefit from reperfusion is strongly time-dependent.

Delays translate into higher mortality and worse outcomes in patients who truly need immediate reperfusion.

Classic evidence for time dependence in primary PCI:

De Luca et al. Time delay to treatment and mortality in primary angioplasty (2004)

And the rationale for rapid reperfusion selection in the fibrinolysis era:

FTT Collaborative Group (1994)

OMI/NOMI matters because it seeks to prevent the specific delay scenario: a time-critical occlusion that fails STEMI criteria and therefore waits.

The “STEMI pathway” also has a harm if specificity is too low

If specificity collapses, systems pay a different cost:

Unnecessary cath lab activations.

Inappropriate fibrinolysis when lytics are used.

Anchoring on MI when the patient has a dangerous mimic requiring different care.

This is why OMI/NOMI should be understood as a disciplined sensitivity gain: it expands the definition of “ECG evidence of occlusion” while keeping interpretive rigor.

A side-by-side comparison for the occlusion question

| Dimension | STEMI/NSTEMI (threshold-centered) | OMI/NOMI (mechanism-centered) | |---|---|---| | Primary trigger | Meets STE cutoff in contiguous leads | Total evidence of acute occlusion physiology | | Typical strength | High operational simplicity and scalability | Better alignment with the time-critical mechanism | | Typical weakness | Lower sensitivity for occlusion when STE is absent or masked | Requires higher ECG expertise and integration | | Where false negatives occur | Posterior OMI, de Winter, subtle LAD occlusion, LBBB/pacing, transient occlusion | Still possible, but reduced by serial ECG, added leads, echo | | Where false positives occur | STE mimics (pericarditis, early repolarization, aneurysm, etc.) | Reduced if differential diagnosis and confirmatory evidence are used |

A practical way to apply OMI/NOMI without abandoning guidelines

OMI/NOMI works best as a layer on top of existing ACS pathways.

A pragmatic approach:

Use standard STEMI criteria as an immediate activation rule.

If STEMI criteria are not met, explicitly ask an occlusion question.

Search for occlusion patterns that are known to bypass STEMI cutoffs.

Repeat ECGs when symptoms persist or recur.

Add posterior leads when V1–V3 suggests a posterior event.

Use bedside echo for new regional wall-motion abnormality when uncertainty is high.

Escalate to immediate reperfusion when the total evidence supports likely occlusion.

This preserves the benefits of STEMI systems while reducing the “false NSTEMI” delay problem described in earlier course modules.

Key takeaways

STEMI/NSTEMI is an effective workflow system, but ST-elevation thresholds are an imperfect surrogate for acute coronary occlusion.

OMI/NOMI is often more accurate for the occlusion question because it raises sensitivity by recognizing occlusion patterns that do not meet classic STE thresholds and by integrating serial ECGs, added leads, bedside echo, and clinical instability.

The outcome relevance is time: when occlusion is present, misclassification into a slower pathway can worsen outcomes, consistent with the well-established time dependence of reperfusion benefit.

Sources

Fourth Universal Definition of Myocardial Infarction (Thygesen et al., 2018)

FTT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction (1994)

2017 ESC Guidelines for STEMI (Ibanez et al., published 2018)

de Winter et al. A new ECG sign of proximal LAD occlusion (2008)

Sgarbossa et al. ECG diagnosis of MI in the presence of LBBB (1996)

Smith et al. Modified Sgarbossa criteria for MI in LBBB (2012)

De Luca et al. Time delay to treatment and mortality in primary angioplasty (2004)

Implementing OMI thinking in practice: algorithms, limitations, and communication with the PCI center

Where this module fits in the course

Earlier modules showed why MI classification evolved:

Q/non‑Q was largely retrospective and poorly suited to time‑critical decisions.

STEMI/NSTEMI became the dominant system trigger for reperfusion because it was practical for thrombolysis and PCI networks.

A key limitation emerged: STEMI/NSTEMI is not the same as occlusion/no occlusion. Some patients with acute coronary occlusion do not meet STEMI millimeter criteria and may be delayed.

The course then introduced OMI/NOMI as a mechanism‑ and urgency‑centered overlay: find the occlusion physiology that should not wait.

This module translates that concept into bedside operations: how to build an OMI‑aware workflow without breaking existing STEMI systems, how to acknowledge limitations, and how to communicate effectively with a PCI center.

!A workflow diagram showing how to layer OMI detection onto standard STEMI/NSTEMI pathways

Definitions used operationally (so the team speaks the same language)

What OMI means in practice

OMI (Occlusion MI) is not a new biomarker definition of infarction. It is a time‑critical mechanism label:

There is strong reason to believe the patient has acute coronary occlusion (or a functional equivalent with critically reduced flow) and therefore needs immediate reperfusion, even if classic STEMI criteria are not met.

What NOMI means in practice

NOMI (Non‑Occlusion MI) refers to MI presentations where there is no compelling evidence of acute occlusion physiology driving urgency, so the patient is managed using risk‑based NSTEMI pathways (early invasive when appropriate, but not necessarily immediate).

Why this overlay is consistent with universal MI definitions

The Fourth Universal Definition of MI defines MI primarily by troponin dynamics plus evidence of ischemia; it does not claim that NSTEMI equals non‑occlusion.

Fourth Universal Definition of Myocardial Infarction (2018)

The core implementation idea: keep the STEMI trigger, add an “occlusion question”

A practical way to implement OMI thinking is not to replace STEMI/NSTEMI categories, but to add a deliberate second question:

After you decide whether the ECG meets STEMI criteria, ask:

> “Despite not meeting STEMI criteria, is this patient showing evidence of acute coronary occlusion physiology that should not wait?”

This avoids two common failure modes:

False reassurance: “No STEMI criteria, therefore safe to wait.”

Uncontrolled overcall: “OMI means activate cath lab for every NSTEMI.”

OMI thinking is a structured escalation pathway, not a blanket policy.

A bedside algorithm for OMI thinking (ED/prehospital to PCI handoff)

This algorithm is written to be used alongside existing STEMI and NSTEMI guidelines.

Stepwise workflow

Start with time and instability

- Note symptom onset time, last-known-well, and whether pain is ongoing. - Identify immediate threats: shock, pulmonary edema, recurrent VT/VF, syncope. - Instability lowers the threshold to treat an “NSTEMI-looking” ECG as possible OMI.

Obtain and interpret a 12‑lead ECG early

- Use standard STEMI criteria as a fast trigger. - Reference frameworks remain guideline-based. - 2017 ESC Guidelines for STEMI (published 2018)

If STEMI criteria are met: activate the immediate reperfusion pathway

- OMI thinking does not slow this down.

If STEMI criteria are not met: screen explicitly for OMI patterns and contexts

Use a short “OMI screen” that is easy to teach and easy to audit.

Repeat ECGs early when symptoms persist or evolve

- Treat the ECG as a dynamic test. - If pain continues, do not wait for troponin before repeating the ECG.

Add leads when the territory may be under-sampled

- Posterior leads (V7–V9) when V1–V3 show suspicious ST depression.

Use bedside echocardiography when uncertainty is high

- A new regional wall-motion abnormality (RWMA) that fits a coronary territory strongly supports an acute culprit process. - A normal quick-look echo does not fully exclude early occlusion, but an abnormal one can justify urgent escalation.

If OMI is suspected: communicate “occlusion concern” and request urgent cath/transfer

- The critical operational step is naming the mechanism concern clearly.

If OMI is not suspected: proceed with standard NSTEMI/NOMI pathways

- Risk stratification, serial troponins, guideline-directed antithrombotic therapy, and early invasive strategy as appropriate. - 2020 ESC Guidelines for NSTE-ACS (published 2021)

The OMI screen: what should trigger urgent escalation despite “no STEMI”

This section is intentionally pragmatic: it lists repeatable patterns that commonly produce “false NSTEMI” delays.

ECG patterns strongly associated with occlusion physiology

Posterior OMI clues

- ST depression in V1–V3 that behaves like a mirror image of posterior ST elevation. - Consider posterior leads V7–V9.

de Winter pattern (often proximal LAD occlusion)

- Upsloping ST depression at the J point in the anterior leads with tall, symmetric T waves. - de Winter et al. (2008)

Subtle anterior OMI

- Minimal ST elevation below thresholds, hyperacute T waves, and reciprocal inferior changes. - The key is coherence: territorial pattern + evolution on repeat ECGs.

LBBB or paced rhythm with occlusion criteria

- Standard STEMI thresholds are unreliable. - Classic Sgarbossa framework: - Sgarbossa et al. (1996) - Modified/proportional approach improved performance: - Smith et al. (2012) Modified Sgarbossa Criteria

Diffuse ST depression with ST elevation in aVR

- A high-risk ischemia pattern that demands urgent senior review and rapid escalation when paired with ongoing symptoms or instability.

Clinical contexts that should “upgrade” your concern

Ongoing or recurrent ischemic pain despite initial therapy.

Shock, acute heart failure, or malignant arrhythmias.

Disproportionate clinical severity compared with a “nondiagnostic” ECG.

New RWMA on bedside echo.

Communication with the PCI center: how to make the call effective

Many missed or delayed OMI cases are not due to a lack of knowledge, but to weak signal transmission between teams. The goal is to communicate in a way that is:

brief,

structured,

evidence-based,

focused on time.

A structured “OMI call” format

Use a consistent template so the receiving interventionalist can decide quickly.

Who and where

- Patient age/sex, location, contact callback.

Why you are calling (one sentence)

- “Concern for acute coronary occlusion physiology despite not meeting STEMI criteria.”

Time and trajectory

- Symptom onset time. - Whether pain is ongoing now. - Any episodes of transient ST changes or prehospital ECG differences.

Hemodynamics and electrical stability

- BP, oxygen requirement, pulmonary edema, shock signs. - Ventricular arrhythmias, high-grade AV block.

ECG description as a pattern (not just ‘no STEMI’)

- Example phrases: - “V1–V3 horizontal ST depression with tall R waves: posterior OMI concern; posterior leads pending/positive.” - “de Winter pattern in V2–V6 with aVR elevation: proximal LAD occlusion concern.” - “LBBB with concordant ST changes meeting modified Sgarbossa.”

Serial data

- Changes on repeat ECGs. - Troponin status if available, but do not use it as the gate for urgency.

Bedside echo

- “New anterior RWMA” or “new inferior RWMA,” if present.

What you are requesting

- “Urgent cath lab evaluation now” or “immediate transfer for PCI-capable care.”

What to send digitally (if your system supports it)

The actual ECG images (initial + repeats).

Posterior leads if performed.

Key vitals trend.

Why language matters

A statement like “NSTEMI” often implies “can wait” in busy systems. If you believe the mechanism is time-critical, say so explicitly:

“This is NSTEMI by criteria but OMI by physiology.”

That sentence forces the receiving team to address the occlusion question rather than the label.

Limitations and risks of implementing OMI thinking

OMI thinking is clinically appealing, but implementation requires acknowledging constraints.

It requires more ECG expertise than a threshold checklist

Pattern recognition (posterior OMI, de Winter, subtle reciprocal changes) is a skill.

LBBB/pacing interpretation needs dedicated criteria.

Mitigation strategies:

Standardized training sets and feedback loops.

Local ECG overread pathways.

Case reviews of “NSTEMI with occluded culprit at cath.”

Risk of over-activation and resource strain

If OMI suspicion is applied indiscriminately, it can:

increase cath lab activations,

increase transfers,

increase exposure to contrast and procedural risks.

Mitigation strategies:

Require coherent territorial ECG evidence and/or supporting data (serial evolution, RWMA, instability).

Track “false positive” activations and refine local criteria.

Not all systems can deliver immediate PCI for every suspected OMI

Operational realities:

long transfer times,

limited cath lab availability,

competing emergencies.

Mitigation strategies:

Define a “fast escalation” tier (urgent cardiology review, immediate repeat ECGs, posterior leads, bedside echo) when cath is not instantly available.

Use early tele-ECG and remote cardiology input.

Troponin can mislead if used incorrectly

Troponin is essential to confirm MI, but not always to detect occlusion urgency.

Early troponin can be normal in early occlusion.

Large troponin values can occur in NOMI contexts.

Mitigation strategy:

Use troponin as support, not as the primary gate for immediate reperfusion when OMI physiology is suspected.

OMI is not identical to “angiographic 100% blockage”

Even if angiography shows subtotal occlusion or spontaneous reperfusion, the patient may have had time-critical physiology. This is one reason the paradigm focuses on urgent ischemia mechanism, not on a simplistic binary.

What success looks like: metrics you can audit locally

To implement OMI thinking as a quality project, measure outcomes your system can track.

Suggested process metrics

Time from first ECG to repeat ECG when pain persists.

Frequency of posterior leads when V1–V3 ST depression is present.

Percentage of LBBB/paced cases assessed using dedicated criteria.

ECG transmission success rate to PCI center.

Suggested clinical endpoints (local QI)

“Occluded culprit found at cath” among NSTEMI-labeled patients.

Delay to angiography for patients later found to have occlusion.

Rates of emergent activation with no culprit lesion (to monitor specificity).

Time-to-treatment remains a major determinant of outcomes in truly time-critical cases.

De Luca et al. (2004) time delay to PCI and mortality

Practical summary: a safe way to adopt OMI thinking

Keep STEMI criteria as a rapid activation trigger.

For non-STEMI ECGs, explicitly ask the occlusion question.

Use an OMI screen: posterior clues, de Winter, subtle LAD patterns with reciprocal changes, LBBB/pacing with modified Sgarbossa, diffuse ST depression with aVR elevation, plus instability.

Make serial ECGs, added leads, and bedside echo routine tools.

Communicate with the PCI center using a structured “OMI call” that states mechanism concern clearly.

Implement with audit and feedback to balance sensitivity gains with resource stewardship.

Sources

Fourth Universal Definition of Myocardial Infarction (2018)

2017 ESC Guidelines for STEMI (published 2018)

2020 ESC Guidelines for NSTE-ACS (published 2021)

de Winter et al. A new ECG sign of proximal LAD occlusion (2008)

Sgarbossa et al. ECG diagnosis of MI in LBBB (1996)

Smith et al. Modified Sgarbossa criteria (2012)

De Luca et al. Time delay to treatment and mortality in primary angioplasty (2004)

2021 AHA/ACC Chest Pain Guideline (2021)